Download PDF

Other users also viewed these articles

Clinical and economic benefit of 32 years of antiretroviral treatment for people living with HIV in Spain: Has it been an efficient intervention? Maria Jesús Pérez-Elías; Daniel Podzamczer Palter; Pere Ventayol Bosch; Inmaculada Jarrín; Antonio Castro; Darío Rubio-Rodríguez; Carlos Rubio-Terrés;
Enferm Infecc Microbiol Clin. 2022;40:550-6
Cost analysis associated with intramuscular versus oral administration of antiretroviral therapy in the management of human immunodeficiency virus infection Vicente Estrada; Juan Emilio Losa; Ramón Morillo-Verdugo; Montserrat Pérez-Encinas; Jesús Santos; Antonio Castro; María Presa González; Laura Salinas-Ortega;
Enferm Infecc Microbiol Clin. 2025;43:251-9
Pre-exposure prophylaxis program in the Community of Madrid: Two years of experience Nuria Fernández Piñeiro; Oskar Ayerdi Aguirrebengoa; Eva Orviz García; Cristina González Pérez; Mar Vera García; Teresa Puerta López; Carmen Rodríguez Martín; Clara Lejarraga Cañas; Jorge Perez García; Begoña Baza Caraciolo; Monserrat González Polo; Florentina Alcudia Pérez; Marta Ruiz Fernández; Natividad Jerez Zamora; Diego Morales Irala; Beatriz López Centeno; Daniele Alioto; José Manuel Martínez Sesmero; Vicente Estrada Pérez; María Teresa Benítez Gimenez; Jorge del Romero Guerrero;
Enferm Infecc Microbiol Clin. 2025;43:133-8